Vol. I  ·  No. 57
Wednesday, November 18, 2026
🔍 Search  ·  278 stories in the archive

Front page › Health › Nov 12, 2026

Cancer Society Now Urges Regular PSA Tests for Most Men 50-69

Black men and men with a strong family history should start annual screening at 45, the updated guideline says.

Painted illustration of a doctor talking with a gray-haired man on an exam table, with a blood sample tube in a rack on the counter in front of them.
AI-generated editorial illustration of a PSA screening conversation. Illustration

The American Cancer Society updated its prostate cancer screening guideline on Thursday, recommending regular PSA blood tests for most men from their 40s or 50s through 69. The update was published in CA: A Cancer Journal for Clinicians.

Men at average risk should get PSA-based screening every two years from 50 to 69. Black men, and other men whose father or brother was diagnosed before 65 or who have several first-degree relatives with the disease, should be screened every year from 45 to 69. Other men with one first-degree relative diagnosed at 65 or older should be screened every two years from 45.

For men 70 to 74, the society calls for an individual decision because the balance of benefits and harms is uncertain. It does not recommend screening at 75 and older, though very healthy men 75 to 79 may continue after talking with a clinician, or for men not expected to live another ten years. A confirmed elevated PSA, 3.0 ng/mL or higher for men 45 to 69, should lead to an MRI or a validated biomarker test to guide biopsy decisions, and low-risk cancers should be managed first with active surveillance.

"PSA testing remains the cornerstone of detecting prostate cancer early, and we now have stronger evidence of its benefits," said Dr. Robert Smith, who directs the society's Center for Early Cancer Detection. The society's chief scientific officer, Dr. William Dahut, said Black men have a 67 percent higher incidence and nearly double the death rate of White men.

Sources

Around the table

Corrections, questions and better ways to do it are welcome. No stock tips, no referral links, no selling. Nothing here is individual advice, and neither is anything in the comments. Comments are public and kept until you ask us to remove them.